0 CHECKOUT

PRODUCT FILTERS

REGION

5
1
1
1

COUNTRY

1

CATEGORIES

  • 22
  • 11
  • 5
  • 4
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

7
8
41
53

PUBLISHED

1
9
26
53

PRODUCT TYPE

45
5
3

Search for: "Sigma Pharmaceuticals Limited-Detailed Product Pipeline"

53 Products

Sigma Pharmaceuticals Ltd in Retailing (Australia)

After a successful redefinition of its business strategy, Sigma Pharmaceuticals has been focusing on strengthening its pharmacy-based retail business. In the first quarter of 2013, Sigma Pharmaceuticals...

Published:  June 2014
Price:  From

Neuropathic Pain - Pipeline Review, H2 2014

Neuropathic Pain - Pipeline Review, H2 2014 Summary This, ‘Neuropathic Pain - Pipeline Review, H2 2014’, provides an overview of the Neuropathic Pain’s therapeutic pipeline. This report provides...

Published:  October 2014
Price:  From

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015 Summary {{Space}}, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015’,...

Published:  June 2015
Price:  From

Colon Cancer - Pipeline Review, H1 2015

Colon Cancer - Pipeline Review, H1 2015 Summary {{Space}}, ‘Colon Cancer - Pipeline Review, H1 2015’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From

Parkinson's Disease - Pipeline Review, H2 2014

Parkinson's Disease - Pipeline Review, H2 2014 Summary This, ‘Parkinson's Disease - Pipeline Review, H2 2014’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This report...

Published:  October 2014
Price:  From

Parkinson's Disease - Pipeline Review, H1 2015

Parkinson's Disease - Pipeline Review, H1 2015 Summary {{Space}}, ‘Parkinson's Disease - Pipeline Review, H1 2015’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This report...

Published:  June 2015
Price:  From

Parkinson's Disease - Pipeline Review, H1 2014

Parkinson's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2014’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This...

Published:  February 2014
Price:  From

Malaria - Pipeline Review, H1 2015

Malaria - Pipeline Review, H1 2015 Summary {{Space}}, ‘Malaria - Pipeline Review, H1 2015’, provides an overview of the Malaria’s therapeutic pipeline. This report provides comprehensive information...

Published:  June 2015
Price:  From

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

The service oriented and dynamic nature of the healthcare industry has led to the discovery of a plethora of treatment options for a wide range of ailments.However, there are certain diseases, termed...

Published:  March 2015
Price:  From

Malaria - Pipeline Review, H2 2014

Malaria - Pipeline Review, H2 2014 Summary This, ‘Malaria - Pipeline Review, H2 2014’, provides an overview of the Malaria’s therapeutic pipeline. This report provides comprehensive information on...

Published:  July 2014
Price:  From

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015 Summary {{Space}}, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Glioblastoma Multiforme (GBM)’s...

Published:  June 2015
Price:  From

Malaria - Pipeline Review, H1 2014

Malaria - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2014’, provides an overview of the Malaria’s therapeutic pipeline. This report provides comprehensive...

Published:  March 2014
Price:  From

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015 Summary {{Space}}, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015’, provides an overview of the Multiple Myeloma (Kahler's...

Published:  June 2015
Price:  From

Neuropathic Pain - Pipeline Review, H1 2015

Neuropathic Pain - Pipeline Review, H1 2015 Summary {{Space}}, ‘Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Neuropathic Pain’s therapeutic pipeline. This report provides...

Published:  June 2015
Price:  From

Breast Cancer - Pipeline Review, H1 2014

Breast Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report...

Published:  March 2014
Price:  From

Non-Hodgkin Lymphoma - Pipeline Review, H1 2014

Non-Hodgkin Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline. This...

Published:  February 2014
Price:  From

Refractory Multiple Myeloma - Pipeline Review, H1 2015

Refractory Multiple Myeloma - Pipeline Review, H1 2015 Summary This, ‘Refractory Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic...

Published:  January 2015
Price:  From

Neuropathic Pain - Pipeline Review, H1 2014

Neuropathic Pain - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2014’, provides an overview of the Neuropathic Pain’s therapeutic pipeline. This...

Published:  February 2014
Price:  From

Ovarian Cancer - Pipeline Review, H1 2015

Ovarian Cancer - Pipeline Review, H1 2015 Summary {{Space}}, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From

Refractory Multiple Myeloma - Pipeline Review, H2 2014

Refractory Multiple Myeloma - Pipeline Review, H2 2014 Summary This, ‘Refractory Multiple Myeloma - Pipeline Review, H2 2014’, provides an overview of the Refractory Multiple Myeloma’s therapeutic...

Published:  July 2014
Price:  From
Loading Indicator

Our Clients

  • Carrefour S.A.
  • Dow Chemical Co Ltd.
  • Motorola Solutions, Inc.
  • Pfizer, Inc.
  • Activision Publishing, Inc.
  • 3M Company
  • Estée Lauder Companies Inc.